PNEUMOSTEM Trademark

Trademark Overview


On Friday, March 5, 2021, a trademark application was filed for PNEUMOSTEM with the United States Patent and Trademark Office. The USPTO has given the PNEUMOSTEM trademark a serial number of 90562624. The federal status of this trademark filing is REGISTERED as of Tuesday, August 16, 2022. This trademark is owned by MEDIPOST CO., LTD.. The PNEUMOSTEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of respiratory organ disorders, for immunity adjustment, for treatment of autoimmune disease, for treatment of cancer, for the treatment of cardiovascular disorders, for the treatment of tumors, and for activating cellular function; biological preparations for medical purposes, namely, for the treatment of respiratory organ disorders, for immunity adjustment, for treatment of autoimmune disease, for treatment of cancer, for the treatment of cardiovascular disorders, for the treatment of tumors, and for activating cellular function; vaccines; bouillons for bacteriological cultures; capsules sold empty for medicines; medicament formulating agents, namely, medicaments to help assist with the regeneration of ligament and tendon fibers; diagnostic reagents for medicinal use; analgesics; antibiotic preparations; blood plasma; medicated serums for the treatment of hair and skin; serotherapeutic medicines, namely, medicated serums for the treatment...
pneumostem

General Information


Serial Number90562624
Word MarkPNEUMOSTEM
Filing DateFriday, March 5, 2021
Status700 - REGISTERED
Status DateTuesday, August 16, 2022
Registration Number6817465
Registration DateTuesday, August 16, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of respiratory organ disorders, for immunity adjustment, for treatment of autoimmune disease, for treatment of cancer, for the treatment of cardiovascular disorders, for the treatment of tumors, and for activating cellular function; biological preparations for medical purposes, namely, for the treatment of respiratory organ disorders, for immunity adjustment, for treatment of autoimmune disease, for treatment of cancer, for the treatment of cardiovascular disorders, for the treatment of tumors, and for activating cellular function; vaccines; bouillons for bacteriological cultures; capsules sold empty for medicines; medicament formulating agents, namely, medicaments to help assist with the regeneration of ligament and tendon fibers; diagnostic reagents for medicinal use; analgesics; antibiotic preparations; blood plasma; medicated serums for the treatment of hair and skin; serotherapeutic medicines, namely, medicated serums for the treatment of immunological disorders; chemotherapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMEDIPOST CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGyeonggi-do 13494
KR

Party NameMEDIPOST CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGyeonggi-do 13494
KR

Party NameMEDIPOST CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGyeonggi-do 13494
KR

Trademark Events


Event DateEvent Description
Tuesday, August 16, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 16, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, July 14, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, May 11, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, July 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 11, 2022TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, January 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 9, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, October 9, 2021LETTER OF SUSPENSION E-MAILED
Saturday, October 9, 2021SUSPENSION LETTER WRITTEN
Tuesday, September 28, 2021ASSIGNED TO EXAMINER
Friday, June 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 9, 2021NEW APPLICATION ENTERED IN TRAM